echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > Blood: Transcription Factor ATF4 Activates BCL11A Transcription to Silent Fetal Hemoglobin Expression

    Blood: Transcription Factor ATF4 Activates BCL11A Transcription to Silent Fetal Hemoglobin Expression

    • Last Update: 2020-06-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Fetal hemoglobin reactivation remains a critical goal for the treatment of patients with sickle cell disease and beta-thalassemiaPrevious researchers have found that fetal gamma-globin gene silencing requires the involvement of red blood cell-specific eIF2 alpha kinase HRI, suggesting that HRI may provide a pharmacological target for raising fetal hemoglobin levelsIn this study, through CRISPR-CAS9-oriented human red blood cell loss screening, the transcription factor ATF4, a known HRI-regulated protein, is a new gamma-bead protein regulatory factorATF4 directly stimulates the transcription of BCL11A by binding with the enhancers of the gamma-pearl transcription inhibitor BCL11A and promoting the enhanced child-starter contact of BCL11ANotably, HRI defective mice showed normal Bcl11a levels, indicating species selective regulation, as explained by the researchers by proving that there is a similar ATF4 sequence on the Bcl11a enhancer in mice that is largely optionalIn summary, this study reveals the linear signaling pathways from HRI to ATF4 to BCL11A to gamma-beadprotein, and illustrates the potential limitations of mouse globin gene regulation models
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.